Literature DB >> 12527910

Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells.

Maurizio Bocchetta1, Lucio Miele, Harvey I Pass, Michele Carbone.   

Abstract

We show that SV40 infection of human mesothelial cells directly causes overexpression of Notch-1, a key cell regulatory gene. Notch-1 induction is achieved at the transcriptional level and requires both the SV40 large T-antigen and the small t-antigen. Notch-1 upregulation is maintained in SV40-transformed human mesothelial clones and in SV40-positive mesotheliomas and derived cell lines. Activation of Notch-1 promotes cell cycle progression and it is required for the growth of SV40-transformed mesothelial cells. Our finding is relevant to the process of SV40-mediated human cell transformation, an effect that cannot be accounted for solely by SV40-Tag inhibition of Rb and p53.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527910     DOI: 10.1038/sj.onc.1206097

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  35 in total

1.  ErbB2 induces Notch1 activity and function in breast cancer cells.

Authors:  Jaime Lindsay; Xuanmao Jiao; Toshiyuki Sakamaki; Mathew C Casimiro; Lawrence A Shirley; Thai H Tran; Xiaoming Ju; Manran Liu; Zhiping Li; Chenguang Wang; Sanjay Katiyar; Mahadev Rao; Kathleen G Allen; Robert I Glazer; Changhui Ge; Pamela Stanley; Michael P Lisanti; Hallgeir Rui; Richard G Pestell
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

Review 2.  Simian virus 40 transformation, malignant mesothelioma and brain tumors.

Authors:  Fang Qi; Michele Carbone; Haining Yang; Giovanni Gaudino
Journal:  Expert Rev Respir Med       Date:  2011-10       Impact factor: 3.772

3.  Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches.

Authors:  Paola Rizzo; Haixi Miao; Gwendolyn D'Souza; Clodia Osipo; Lynda L Song; Jieun Yun; Huiping Zhao; Joaquina Mascarenhas; Debra Wyatt; Giovanni Antico; Lu Hao; Katharine Yao; Prabha Rajan; Chindo Hicks; Kalliopi Siziopikou; Suzanne Selvaggi; Amina Bashir; Deepali Bhandari; Adriano Marchese; Urban Lendahl; Jian-Zhong Qin; Debra A Tonetti; Kathy Albain; Brian J Nickoloff; Lucio Miele
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

4.  Tissue Tropism of SV40 Transformation of Human Cells: Role of the Viral Regulatory Region and of Cellular Oncogenes.

Authors:  Lei Zhang; Fang Qi; Giovanni Gaudino; Oriana Strianese; Haining Yang; Paul Morris; Harvey I Pass; Vivek R Nerurkar; Maurizio Bocchetta; Michele Carbone
Journal:  Genes Cancer       Date:  2010-10

5.  Role of Notch signal transduction in Kaposi's sarcoma-associated herpesvirus gene expression.

Authors:  Heesoon Chang; Dirk P Dittmer; Young C Shin; Shin-Young Chul; Youngkwon Hong; Jae U Jung
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Activation of the tumor-specific death effector apoptin and its kinase by an N-terminal determinant of simian virus 40 large T antigen.

Authors:  Ying-Hui Zhang; Klaas Kooistra; Alexandra Pietersen; Jennifer L Rohn; Mathieu H M Noteborn
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 7.  Notch inhibitors for cancer treatment.

Authors:  Ingrid Espinoza; Lucio Miele
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

Review 8.  Emergent human pathogen simian virus 40 and its role in cancer.

Authors:  Regis A Vilchez; Janet S Butel
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

9.  Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bim.

Authors:  J Konishi; F Yi; X Chen; H Vo; D P Carbone; T P Dang
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

Review 10.  Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors.

Authors:  Shoshana J Weiner; Siyamek Neragi-Miandoab
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-12       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.